Literature DB >> 27906794

Health-related Quality of Life (HR-QOL) and Chronic Health Conditions in Survivors of Childhood Acute Myeloid Leukemia (AML) with Down Syndrome (DS): A Report From the Children's Oncology Group.

Kris Ann P Schultz1, Lu Chen, Alicia Kunin-Batson, Zhengjia Chen, William G Woods, Alan Gamis, Toana Kawashima, Kevin C Oeffinger, H Stacy Nicholson, Joseph P Neglia.   

Abstract

Survival rates for children with Down syndrome (DS) and acute myeloid leukemia (AML) are high; however, little is known regarding the health-related quality of life (HR-QOL) of these survivors. Individuals who survived ≥5 years following diagnosis of childhood AML were invited to complete parent or patient-report surveys measuring HR-QOL and chronic health conditions. In total, 26 individuals with DS had a median age at diagnosis of 1.8 years (range, 0.77 to 10.9 y) and median age at interview of 15 years (range, 8.3 to 27.6 y). Participants with DS and AML were compared with AML survivors without DS whose caregiver completed a HR-QOL survey (CHQ-PF50). In total, 77% of survivors with DS reported ≥1 chronic health condition compared with 50% of AML survivors without DS (P=0.07). Mean physical and psychosocial QOL scores for children with DS and AML were statistically lower than the population mean, though not discrepant from AML survivors without DS. Although the overall prevalence of chronic health conditions in survivors with DS is higher than in survivors without DS, prior studies of children with DS have reported similarly high rates of chronic health conditions, suggesting that AML therapy may not substantially increase this risk.

Entities:  

Mesh:

Year:  2017        PMID: 27906794      PMCID: PMC5161561          DOI: 10.1097/MPH.0000000000000707

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  25 in total

1.  A meta-analysis of the neurocognitive sequelae of treatment for childhood acute lymphocytic leukemia.

Authors:  Laura K Campbell; Mary Scaduto; William Sharp; Lynette Dufton; Deborah Van Slyke; James A Whitlock; Bruce Compas
Journal:  Pediatr Blood Cancer       Date:  2007-07       Impact factor: 3.167

Review 2.  Postremission therapy for children with acute myeloid leukemia: the children's cancer group experience in the transplant era.

Authors:  T A Alonzo; R J Wells; W G Woods; B Lange; R B Gerbing; A B Buxton; S Neudorf; J Sanders; F O Smith; S A Feig
Journal:  Leukemia       Date:  2005-06       Impact factor: 11.528

3.  Health-related quality of life in childhood cancer: discrepancy in parent-child reports.

Authors:  R B Levi; D Drotar
Journal:  Int J Cancer Suppl       Date:  1999

Review 4.  Health and disease in adults with Down syndrome.

Authors:  Eva Albertsen Malt; Renate Charlotte Dahl; Trine Marie Haugsand; Ingebjørg H Ulvestad; Nina Merete Emilsen; Børre Hansen; Yon Eduin Galezo Cardenas; Rolf Olof Skøld; Anne Tove Berge Thorsen; Eva Merete Male Davidsen
Journal:  Tidsskr Nor Laegeforen       Date:  2013-02-05

5.  Cardiomyopathy in children with Down syndrome treated for acute myeloid leukemia: a report from the Children's Oncology Group Study POG 9421.

Authors:  Maureen M O'Brien; Jeffrey W Taub; Myron N Chang; Gita V Massey; Kimo C Stine; Susana C Raimondi; David Becton; Yaddanapudi Ravindranath; Gary V Dahl
Journal:  J Clin Oncol       Date:  2008-01-20       Impact factor: 44.544

6.  Morbidity and medication in a large population of individuals with Down syndrome compared to the general population.

Authors:  Myriam Alexander; Hans Petri; Yingjie Ding; Christoph Wandel; Omar Khwaja; Nadia Foskett
Journal:  Dev Med Child Neurol       Date:  2015-08-18       Impact factor: 5.449

7.  Down syndrome and acute leukemia in children: a 10-year retrospective survey from Childrens Cancer Study Group.

Authors:  L L Robison; M E Nesbit; H N Sather; C Level; N Shahidi; A Kennedy; D Hammond
Journal:  J Pediatr       Date:  1984-08       Impact factor: 4.406

Review 8.  Optimal treatment intensity in children with Down syndrome and myeloid leukaemia: data from 56 children treated on NOPHO-AML protocols and a review of the literature.

Authors:  Lotte Abildgaard; Eva Ellebaek; Göran Gustafsson; Jonas Abrahamsson; Liisa Hovi; Gudmundur Jonmundsson; Bernward Zeller; Henrik Hasle
Journal:  Ann Hematol       Date:  2006-03-04       Impact factor: 3.673

9.  The contribution of neurocognitive functioning to quality of life after childhood acute lymphoblastic leukemia.

Authors:  Alicia Kunin-Batson; Nina Kadan-Lottick; Joseph P Neglia
Journal:  Psychooncology       Date:  2014-02-04       Impact factor: 3.894

10.  Development, problem behavior, and quality of life in a population based sample of eight-year-old children with Down syndrome.

Authors:  Helma B M van Gameren-Oosterom; Minne Fekkes; Simone E Buitendijk; Ashna D Mohangoo; Jeanet Bruil; Jacobus P Van Wouwe
Journal:  PLoS One       Date:  2011-07-21       Impact factor: 3.240

View more
  4 in total

Review 1.  Trisomy 21 with t(5; 11) chromosomal translocation as new unfavorable cytogenetic abnormalities in pediatric acute myeloid leukemia type M2: One case report of nine-year follow-up and literature review.

Authors:  Lin Wang; Xiao-Yan Wu; Run-Ming Jin; Bing-Yu Zhang; Yi-Ning Qiu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-10-20

2.  Long-term sequelae in survivors of childhood leukemia with Down syndrome: A childhood cancer survivor study report.

Authors:  Robert E Goldsby; Kayla L Stratton; Shannon Raber; Arthur Ablin; Louise C Strong; Kevin Oeffinger; Charles A Sklar; Gregory T Armstrong; Leslie L Robison; Smita Bhatia; Wendy M Leisenring
Journal:  Cancer       Date:  2017-11-03       Impact factor: 6.860

3.  Quality of life in pediatric acute myeloid leukemia: Report from the Children's Oncology Group.

Authors:  Rajaram Nagarajan; Robert Gerbing; Todd Alonzo; Donna L Johnston; Richard Aplenc; Edward A Kolb; Soheil Meshinchi; Lamia P Barakat; Lillian Sung
Journal:  Cancer Med       Date:  2019-06-12       Impact factor: 4.452

4.  Long-term small-fiber neuropathy and pain sensitization in survivors of pediatric acute lymphoblastic leukemia after stem cell transplantation.

Authors:  Sascha Lieber; Victoria Ruscher; Jörn-Sven Kühl; Johannes Schulte; Markus Blankenburg; Tobias Reindl; Pablo Hernáiz Driever
Journal:  J Cancer Res Clin Oncol       Date:  2020-04-28       Impact factor: 4.553

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.